One Barrier to Cannabis Research Removed, Others Remain

Several mainstream media outlets are reporting that the US Department of Health and Human Services has removed a requirement mandating that all investigative protocols seeking cannabis for clinical study must undergo a Public Health Service review. The review process, which was enacted in 1999 and applied only to clinical studies involving cannabis, was long criticized by advocates as unnecessarily burdensome and time-consuming.

Commenting on the change, a Health and Human Services spokeswoman said, “The department expects the action announced today will help facilitate further research to advance our understanding about the health risks and any potential benefits of medications using marijuana or its components or derivatives.”

But as I point out in today’s news wire coverage here, such claims are likely overstated.

That is because unique hurdles to clinical cannabis research will continue to exist as long as the plant is a) classified as a schedule I controlled substance defined as possessing no medical use and b) the source material for clinical trials must be provided by the US government’s lone supplier, the University of Mississippi (which is overseen by the US National Institute on Drug Abuse).

– See more at: http://blog.norml.org/2015/06/23/one-barrier-to-cannabis-research-removed-others-remain/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+NORMLBlog+%28NORML+Blog%29#sthash.rVm2EarW.dpuf

Annunci

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione / Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione / Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione / Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione / Modifica )

Connessione a %s...